Even though the patients who experienced CNS relapse were diagnosed all in WHO era except for one patient who was diagnosed with ALK-ALCL in 1999, cumulative incidence for subtypes should be interpreted with caution. This evidence concerns the gene ALK and anaplastic large cell lymphoma.